Literature DB >> 3500965

Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae.

J H Jorgensen1, J S Redding, L A Maher, A W Howell.   

Abstract

The need for complex growth media has complicated routine susceptibility testing of Haemophilus influenzae because of antagonism of certain antimicrobial agents by the medium or because of difficulties in interpretation of growth endpoints. Haemophilus test medium (HTM) is a simple, transparent medium for broth- or agar-based tests with H. influenzae. HTM incorporates Mueller-Hinton medium with additions of 15 micrograms of hematin per ml, 15 micrograms of NAD per ml, and 5 mg of yeast extract per ml as growth-promoting additives. Agar or broth microdilution MICs of 10 antimicrobial agents for a collection of 179 H. influenzae isolates determined by using HTM compared favorably with MICs determined by the conventional agar or broth dilution methods recommended by the National Committee for Clinical Laboratory Standards. Disk diffusion tests performed with HTM allowed accurate categorization of susceptible and resistant strains and were easier to interpret than tests performed with Mueller-Hinton chocolate agar. A particular advantage of HTM was the reliability of broth- or agar-based test results with trimethoprim-sulfamethoxazole. The results of the study suggest modification of current National Committee for Clinical Laboratory Standards MIC-interpretive criteria for H. influenzae with amoxicillin-clavulanate, chloramphenicol, and trimethoprim-sulfamethoxazole. Error rate-bounded analysis of MICs and disk diffusion zone sizes also suggest modified zone-interpretive criteria for ampicillin, amoxicillin-clavulanate, chloramphenicol, and tetracycline with HTM or conventional media. Interpretive zone sizes are newly proposed for cefaclor and rifampin disk diffusion tests.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3500965      PMCID: PMC269421          DOI: 10.1128/jcm.25.11.2105-2113.1987

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  30 in total

1.  Meningitis due to chloramphenicol-resistant Haemophilus influenzae type b.

Authors:  A L Kinmonth; C N Storrs; R G Mitchell
Journal:  Br Med J       Date:  1978-03-18

2.  Disc inhibition zones of rifampin against Haemophilus influenzae type b.

Authors:  J N Walterspiel; E O Mason; S L Kaplan
Journal:  Pediatr Infect Dis       Date:  1985 Mar-Apr

3.  Modified microdilution susceptibility test for staphylococci, streptococci and Haemophilus spp.

Authors:  R J Fass; V L Helsel
Journal:  Eur J Clin Microbiol       Date:  1984-08       Impact factor: 3.267

4.  Susceptibility in vitro of Haemophilus influenzae to penicillin G, penicillin V and ampicillin. Incubation of strains from acute otitis media in air and in CO2-atmosphere.

Authors:  C Kamme
Journal:  Acta Pathol Microbiol Scand       Date:  1969

5.  Ampicillin resistance in Haemophilus influenzae as determined by a rapid test for beta-lactamase production.

Authors:  C Thornsberry; L A Kirven
Journal:  Antimicrob Agents Chemother       Date:  1974-11       Impact factor: 5.191

6.  Antimicrobial resistance of Haemophilus species in patients with chronic bronchitis.

Authors:  C A Kauffman; A G Bergman; C S Hertz
Journal:  Am Rev Respir Dis       Date:  1979-12

7.  Haemophilus influenzae type B resistant to tetracycline isolated from children with meningitis.

Authors:  D Hansman
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

8.  Increasing ampicillin-resistance rates in Hemophilus influenzae meningitis.

Authors:  G R Istre; J S Conner; M P Glode; R S Hopkins
Journal:  Am J Dis Child       Date:  1984-04

9.  Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study.

Authors:  G V Doern; J H Jorgensen; C Thornsberry; D A Preston
Journal:  Diagn Microbiol Infect Dis       Date:  1986-02       Impact factor: 2.803

10.  Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae.

Authors:  D A Strandberg; J H Jorgensen; D J Drutz
Journal:  Diagn Microbiol Infect Dis       Date:  1984-09       Impact factor: 2.803

View more
  94 in total

1.  Identification of beta-lactamase-negative, ampicillin-resistant strains of Haemophilus influenzae with four methods and eight media.

Authors:  A L Barry; P C Fuchs; S D Brown
Journal:  Antimicrob Agents Chemother       Date:  2001-05       Impact factor: 5.191

2.  Interpretive criteria and quality control parameters for testing susceptibility of Haemophilus influenzae to enoxacin, ofloxacin, and temafloxacin.

Authors:  A L Barry; J H Jorgensen; D J Hardy; S D Allen; C N Baker; P C Fuchs; J C McLaughlin
Journal:  J Clin Microbiol       Date:  1992-11       Impact factor: 5.948

3.  In vitro activity of clarithromycin and its 14-hydroxy-metabolite against 203 strains of Haemophilus influenzae.

Authors:  M G Bergeron; M Bernier; J L'Ecuyer
Journal:  Infection       Date:  1992 May-Jun       Impact factor: 3.553

4.  Preliminary interpretive criteria for the Haemophilus Test Medium method using 30 micrograms cefepime disks.

Authors:  R N Jones
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-02       Impact factor: 3.267

Review 5.  In vitro susceptibility testing of Haemophilus influenzae: review of new National Committee for Clinical Laboratory Standards recommendations.

Authors:  G V Doern
Journal:  J Clin Microbiol       Date:  1992-12       Impact factor: 5.948

6.  In vitro potency of nine orally administered antimicrobial agents against three respiratory tract pathogens.

Authors:  A L Barry
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-09       Impact factor: 3.267

7.  Disk diffusion quality control guidelines for Haemophilus susceptibility tests using cefdinir, CI-960, fleroxacin, temafloxacin, and trospectomycin.

Authors:  M J Bale; R N Jones; M E Erwin; F P Koontz; E H Gerlach; P R Murray; J A Washington
Journal:  J Clin Microbiol       Date:  1992-03       Impact factor: 5.948

8.  The Second European Collaborative Study on the frequency of antimicrobial resistance in Haemophilus influenzae.

Authors:  F H Kayser; G Morenzoni; P Santanam
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1990-11       Impact factor: 3.267

9.  In vitro activity of the new fluoroquinolone CP-99,219.

Authors:  H C Neu; N X Chin
Journal:  Antimicrob Agents Chemother       Date:  1994-11       Impact factor: 5.191

10.  N-acetyl-D-glucosamine medium improves recovery of Haemophilus influenzae from sputa of patients with cystic fibrosis.

Authors:  L V Möller; L van Alphen; H Grasselier; J Dankert
Journal:  J Clin Microbiol       Date:  1993-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.